Early Christmas Sale - Ends Soon!
-35% Off Everything
Bristol-Myers Squibb Company (BMY)
Last Price$59.2(0.1%)
Market Cap$97.6B
BMY overview
Crunching data... Almost there!
1W 2.5%
1M (1.7%)
6M 39.4%
YTD 14.9%
1Y 17.9%
3Y 3.9%
5Y 7.7%
10Y 32.2%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
BMY key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
BMY Intrinsic value
BMY Intrinsic value overview
BMY Historical intrinsic value
BMY Financials
BMY Income statement
Crunching data... Almost there!
BMY Balance sheet
Crunching data... Almost there!
BMY Cash flow statement
Crunching data... Almost there!
BMY Financial ratios
BMY Growth
Crunching data... Almost there!
BMY Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more BMY fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of Bristol-Myers Squibb Company (BMY) stock?
As of today, intrinsic value of Bristol-Myers Squibb Company is $82.8.
Is Bristol-Myers Squibb Company (BMY) stock undervalued or overvalued?
As of today, Bristol-Myers Squibb Company is undervalued by 43.5%, compared to the current market share price of $59.2.
What is Bristol-Myers Squibb Company (BMY) stock rating?
As of today, Bristol-Myers Squibb Company has a stock rating of 7 (out of 10), which is considered Great.
is Bristol-Myers Squibb Company (BMY) a good stock to buy?
As of today, Bristol-Myers Squibb Company has a Great stock rating, which is 43.5% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.